Oculopharyngeal muscular dystrophy (OPMD) is a rare genetic disorder characterized by progressive muscle weakness in the eyes, face, and throat. The ICD-10 code for OPMD is G71.11. Unfortunately, there is no specific ICD-9 code for OPMD as it was replaced by ICD-10 in 2015. OPMD typically manifests in adulthood and can lead to difficulty swallowing and speaking. Genetic testing is often required for diagnosis.
Oculopharyngeal muscular dystrophy (OPMD) is a rare genetic disorder characterized by progressive muscle weakness in the eyes (oculo-), throat (pharyngeal), and sometimes other muscles. The ICD-10 code for OPMD is G71.11, which falls under the broader category of "primary disorders of muscles."
On the other hand, the ICD-9 code for OPMD is 359.1. However, it is important to note that ICD-9 codes are no longer in use as of October 1, 2015. They have been replaced by ICD-10 codes, which provide more detailed and specific classifications for medical conditions.
OPMD typically manifests in adulthood, usually between the ages of 40 and 60, and is caused by a mutation in the PABPN1 gene. Symptoms may include droopy eyelids, difficulty swallowing, voice changes, and muscle weakness. Although there is currently no cure for OPMD, various interventions such as physical therapy, speech therapy, and surgical interventions can help manage symptoms and improve quality of life for affected individuals.
It is important for individuals with OPMD to consult with healthcare professionals for accurate diagnosis, treatment, and ongoing management of this condition.